Jarecki J[Author] - Search Results

Year	Number of Results
1986	1
1993	1
1994	1
1995	1
1999	1
2001	1
2003	1
2005	1
2007	1
2008	4
2009	1
2010	3
2011	2
2012	1
2013	3
2014	2
2015	1
2016	1
2017	4
2018	5
2019	3
2020	10
2021	10
2022	10
2023	9
2024	2

1

Knee Cartilage Lesion Management-Current Trends in Clinical Practice.

Jarecki J, Waśko MK, Widuchowski W, Tomczyk-Warunek A, Wójciak M, Sowa I, Blicharski T. Jarecki J, et al. J Clin Med. 2023 Oct 10;12(20):6434. doi: 10.3390/jcm12206434. J Clin Med. 2023. PMID: 37892577 Free PMC article. Review.

2

Identifying Biomarkers of Spinal Muscular Atrophy for Further Development.

Glascock J, Darras BT, Crawford TO, Sumner CJ, Kolb SJ, DiDonato C, Elsheikh B, Howell K, Farwell W, Valente M, Petrillo M, Tingey J, Jarecki J. Glascock J, et al. Among authors: jarecki j. J Neuromuscul Dis. 2023;10(5):937-954. doi: 10.3233/JND-230054. J Neuromuscul Dis. 2023. PMID: 37458045 Free PMC article.

3

Interview with Jill Jarecki, PhD.

Jarecki J, Glaser V. Jarecki J, et al. Assay Drug Dev Technol. 2014 Aug;12(6):311-4. doi: 10.1089/adt.2014.1505. Assay Drug Dev Technol. 2014. PMID: 25147905 Free PMC article. No abstract available.

4

A framework for building cognitive process models.

Jarecki JB, Tan JH, Jenny MA. Jarecki JB, et al. Psychon Bull Rev. 2020 Dec;27(6):1218-1229. doi: 10.3758/s13423-020-01747-2. Psychon Bull Rev. 2020. PMID: 32632887 Free PMC article. Review.

5

HYALURONIC ACID IN ORTHOPEDICS.

Kosiński J, Jarecki J, Przepiorka-Kosińska J, Ratajczak M. Kosiński J, et al. Among authors: jarecki j. Wiad Lek. 2020;73(9 cz. 1):1878-1881. Wiad Lek. 2020. PMID: 33099534

6

[Cartilage ageing and treatment possibilities].

Jarecki J. Jarecki J. Wiad Lek. 2019;72(9 cz 1):1671-1675. Wiad Lek. 2019. PMID: 31586981 Review. Polish.

7

Precision and plasticity during Drosophila neuromuscular development.

Keshishian H, Chang TN, Jarecki J. Keshishian H, et al. Among authors: jarecki j. FASEB J. 1994 Jul;8(10):731-7. doi: 10.1096/fasebj.8.10.8050672. FASEB J. 1994. PMID: 8050672 Review.

8

Cure SMA and our patient community celebrate the first approved drug for SMA.

Glascock J, Lenz M, Hobby K, Jarecki J. Glascock J, et al. Among authors: jarecki j. Gene Ther. 2017 Sep;24(9):498-500. doi: 10.1038/gt.2017.39. Epub 2017 May 15. Gene Ther. 2017. PMID: 28504658 Review.

9

The SMA Clinical Trial Readiness Program: creation and evaluation of a program to enhance SMA trial readiness in the United States.

Peterson I, Cruz R, Sarr F, Stanley AM, Jarecki J. Peterson I, et al. Among authors: jarecki j. Orphanet J Rare Dis. 2020 May 22;15(1):118. doi: 10.1186/s13023-020-01387-8. Orphanet J Rare Dis. 2020. PMID: 32443972 Free PMC article. Review.

10

Assays for the identification and prioritization of drug candidates for spinal muscular atrophy.

Cherry JJ, Kobayashi DT, Lynes MM, Naryshkin NN, Tiziano FD, Zaworski PG, Rubin LL, Jarecki J. Cherry JJ, et al. Among authors: jarecki j. Assay Drug Dev Technol. 2014 Aug;12(6):315-41. doi: 10.1089/adt.2014.587. Assay Drug Dev Technol. 2014. PMID: 25147906 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

71 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year